Skip to content
10-K

Annual Report

XTANT MEDICAL HOLDINGS, INC. XTNT

0001493152-26-013792

← back to feed
Filed
Mar 31, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 25, 2026 140.07M sh
Shares Diluted FY 2025 · Dec 31, 2025 150.04M sh
Shares Diluted FY 2025 · Dec 31, 2024 133.67M sh
Capex FY 2025 · Dec 31, 2025 $2.38M
Capex FY 2025 · Dec 31, 2024 $4.11M
Operating Cash Flow FY 2025 · Dec 31, 2025 $12.55M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$11.9M
Long Term Debt FY 2025 · Dec 31, 2025 $11.03M
Long Term Debt FY 2025 · Dec 31, 2024 $22.04M
Cash And Equivalents FY 2025 · Dec 31, 2025 $17.05M
Cash And Equivalents FY 2025 · Dec 31, 2024 $6.2M
Stockholders Equity FY 2025 · Dec 31, 2025 $50.95M
Stockholders Equity FY 2025 · Dec 31, 2024 $42.96M
Stockholders Equity FY 2025 · Dec 31, 2023 $51.35M
Current Liabilities FY 2025 · Dec 31, 2025 $29.48M
Current Liabilities FY 2025 · Dec 31, 2024 $28.58M
Total Liabilities FY 2025 · Dec 31, 2025 $43.19M
Total Liabilities FY 2025 · Dec 31, 2024 $50.87M
Current Assets FY 2025 · Dec 31, 2025 $78.25M
Current Assets FY 2025 · Dec 31, 2024 $67.12M
Total Assets FY 2025 · Dec 31, 2025 $94.15M
Total Assets FY 2025 · Dec 31, 2024 $93.84M
Eps Diluted FY 2025 · Dec 31, 2025 $0.03
Eps Diluted FY 2025 · Dec 31, 2024 −$0.12
Eps Basic FY 2025 · Dec 31, 2025 $0.04
Eps Basic FY 2025 · Dec 31, 2024 −$0.12
Sga Expense FY 2025 · Dec 31, 2025 $29.38M
Sga Expense FY 2025 · Dec 31, 2024 $28.69M
Rd Expense FY 2025 · Dec 31, 2025 $2.1M
Rd Expense FY 2025 · Dec 31, 2024 $2.39M
Net Income FY 2025 · Dec 31, 2025 $4.97M
Net Income FY 2025 · Dec 31, 2024 −$16.45M
Operating Income FY 2025 · Dec 31, 2025 $7.28M
Operating Income FY 2025 · Dec 31, 2024 −$12.07M
Gross Profit FY 2025 · Dec 31, 2025 $84.27M
Gross Profit FY 2025 · Dec 31, 2024 $68.22M
Cost Of Revenue FY 2025 · Dec 31, 2025 $49.65M
Cost Of Revenue FY 2025 · Dec 31, 2024 $49.05M
Revenue FY 2025 · Dec 31, 2025 $133.93M
Revenue FY 2025 · Dec 31, 2024 $117.27M